Infectious Disease Doctors in Paterson, NJ Accepting Medicare

4 Infectious Disease doctors found. Showing 1 - 4

Michael Lange, M.D. Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 160 Market St, Comprehensive Care Center, Paterson, NJ 07505 Phone: 973-754-4701

Dr. Alexis Corazon, MD Internal Medicine - Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 355 Totowa Ave, Paterson, NJ 07502 Phone: 973-389-1300    Fax: 973-389-0138

Simi Philip, Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 703 Main St, Paterson, NJ 07503 Phone: 973-754-2000

Ali Zahran, M.D. Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 703 Main St, Department: Community Medicine, Paterson, NJ 07503 Phone: 973-754-2000

News Archive

Alexion announces results of eculizumab two open-label Phase 2 studies for aHUS treatment

Alexion Pharmaceuticals, Inc. today announced that its two open-label Phase 2 studies investigating eculizumab (Soliris) as a treatment for patients with atypical Hemolytic Uremic Syndrome (aHUS) have met the primary and key secondary endpoints with high clinical and statistical significance, in interim analyses.

Researchers discover evolutionary nature of bacteria to spread chronic infectious disease

Researchers from the Center for Genomic Sciences at Allegheny General Hospital (AGH) in Pittsburgh have made a landmark discovery about the evolutionary nature of bacteria in the setting of chronic infectious disease. Reporting today in the journal PLos Pathogens, the AGH team documents for the first time that bacteria engage in a process called horizontal gene transfer to evolve rapidly during the course of a single infection.

Avastin and chemo combo may offer hope for glioblastoma multiforme patients

Brain cancer patients with the poorest prognosis - those with a type of deadly tumor known as glioblastoma multiforme (GBM) - may survive longer with a drug that chokes off a tumor's blood supply.

XOMA expands anti-inflammatory antibody intellectual property portfolio

XOMA Ltd., a leader in the discovery and development of therapeutic antibodies, announced that the U.S. Patent and Trademark Office has issued two new patents that significantly expand the company's intellectual property portfolio relating to its anti-inflammatory antibody, XOMA 052, that targets interleukin-1 beta (IL-1 beta).

District of Columbia HIV/AIDS prevalence at 3%, report says

At least 3% of District of Columbia residents are living with HIV/AIDS, greater than the 1% level that constitutes a "generalized and severe" epidemic, according to a 2008 report to be released Monday by the city's HIV/AIDS Administration, the Washington Post reports.

Read more Medical News

› Verified 2 days ago